(Q84066832)
Statements
Clinical benefit of high-sensitivity KRAS mutation testing in metastatic colorectal cancer treated with anti-EGFR antibody therapy (English)
Tetsuo Kimura
Koichi Okamoto
Hiroshi Miyamoto
Masako Kimura
Shinji Kitamura
Hidetaka Takenaka
Toshiya Okahisa
Eriko Aoyagi
Mayumi Kajimoto
Yasushi Tsuji
Takahiro Kogawa
Akihito Tsuji
Tetsuji Takayama
28 April 2012